ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 71 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,271,000 | +11.4% | 189,259 | 0.0% | 0.02% | +17.6% |
| Q1 2015 | $2,038,000 | +107.5% | 189,259 | -2.3% | 0.02% | +70.0% |
| Q4 2014 | $982,000 | +52.0% | 193,640 | -20.8% | 0.01% | +25.0% |
| Q3 2014 | $646,000 | -34.5% | 244,619 | 0.0% | 0.01% | -33.3% |
| Q2 2014 | $986,000 | -12.0% | 244,619 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $1,120,000 | +1.5% | 244,619 | -3.8% | 0.01% | -12.5% |
| Q4 2013 | $1,103,000 | +10.1% | 254,199 | 0.0% | 0.02% | +14.3% |
| Q3 2013 | $1,002,000 | +86.9% | 254,199 | 0.0% | 0.01% | +27.3% |
| Q2 2013 | $536,000 | – | 254,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |